All samples analyzed by immunohistochemistry were positive for IFN-β, although epithelial tissues, and alveolar macrophages from stable COPD patients (Figs 1 and 2) showed significantly lower labeling scores than those from the control groups (Table 2). This evidence concerns the gene IFNB1 and chronic obstructive pulmonary disease.